Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Peptron inc.

Minute Insight: Nutromics Raises $14m As Dexcom Signals Move Into Wider Sensing Capabilities

Nutromics is working on a portfolio of aptamer-based sensors capable of measuring a wide range of analytes found in interstitial fluid.

Minute Insights Financing

Venture Funding Deals: Two Companies With China Ties Raise $260m Each

Suzhou-based immuno-oncology specialist CStone raised a $260m Series B round and Brii launched with $260m in Series A cash to develop drugs for the China market. Also, multiple start-ups launched recently with more than $50m in Series A rounds, including Ansun, Beam, Casma, Celsius and Neurana.

Deals Financing

Peptron Eyes Differentiation As Exenatide Progresses For Parkinson’s

With the recent completion of GMP manufacturing facilities and sizable funding, South Korean peptide therapeutics company Peptron is set to begin a Phase II clinical trial of sustained release exenatide for Parkinsons, which if successful could pave the way to a first-in-class, disease-modifying treatment for the disease.

Research & Development Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • ADMET
UsernamePublicRestriction

Register